Saturday, May 16, 2020 12:42:04 AM
In a few days we will know if Brilacidin is active against Covid 19 infected respiratory epithelial cells after a battery of tests.
I have been told by a biologist I trust that Vero monkey cells and Human cells are very similar genetically which means there is a substantial chance the second round of RBL tests will be positive. If positive Brilacidin will move to clinical trials.
Obviously it goes without saying, the future testing of Brilacidin against Covid19 may not work out and IPIX will have a substantial set back. However, it will have received a substantial amount of research and development with little expense.
On the other hand if Brilacidin proves to be an effective treatment for Covid 19, it will save an untold number of lives and eliminate much loss and suffering. Mr Ehrlich and the IPIX shareholders will be richly rewarded.
The Polymedix scientists, DeGrado,Klein,Scott and others who developed Brilacidin will have a shot at the Nobel prize. The field of defensin mimetics and protein chemistry they have pioneered will be validated and a bright future for other revolutionary medications and treatments will follow. Brilacidin's research and development will continue and multiple future indications are possible.
Mr Ehrlicht has accomplished a great deal. It is disappointing and discouraging you and others do not appreciate his efforts and abilities.
All IMO
Best wishes,Farrell
Imagine Leo telling a reporter he is a genius. A genius with a one employee company.
Recent IPIX News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/01/2024 01:30:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/05/2023 09:25:58 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 09:05:44 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/15/2023 01:00:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2023 08:15:25 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 09/28/2023 01:00:08 PM
FEATURED Cannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA • Apr 25, 2024 8:52 AM
Bantec Reports an Over 50 Percent Increase in Sales and Profits in Q1 2024 from Q1 2023 • BANT • Apr 25, 2024 10:00 AM
Kona Gold Beverages, Inc. Announces Name Change to NuVibe, Inc. and Initiation of Ticker Symbol Application Process • KGKG • Apr 25, 2024 8:30 AM
Axis Technologies Group and Carbonis Forge Ahead with New Digital Carbon Credit Technology • AXTG • Apr 24, 2024 3:00 AM
North Bay Resources Announces Successful Equipment Test at Bishop Gold Mill, Inyo County, California • NBRI • Apr 23, 2024 9:41 AM
Epazz, Inc.: CryObo, Inc. solar Bitcoin operations will issue tokens • EPAZ • Apr 23, 2024 9:20 AM